Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,041 DKK | +0.74% | +2.56% | -5.29% |
15/05 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
15/05 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.29% | 1.92TCr | |
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr | |
-24.50% | 823.19Cr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Sector Update: Health Care Stocks Softer Tuesday Afternoon